Patterson Drug Company v. Kingery

305 F. Supp. 821, 1969 U.S. Dist. LEXIS 13120, 1970 Trade Cas. (CCH) 73,097
CourtDistrict Court, W.D. Virginia
DecidedSeptember 16, 1969
DocketCiv. A. 68-C-46-L
StatusPublished
Cited by12 cases

This text of 305 F. Supp. 821 (Patterson Drug Company v. Kingery) is published on Counsel Stack Legal Research, covering District Court, W.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Patterson Drug Company v. Kingery, 305 F. Supp. 821, 1969 U.S. Dist. LEXIS 13120, 1970 Trade Cas. (CCH) 73,097 (W.D. Va. 1969).

Opinion

BUTZNER, Circuit Judge:

The Patterson Drug Company, doing business in Virginia as Reveo Drug Centers, and Donald J. Deaton, a pharmacist in charge of one of Revco’s stores, seek an injunction under 28 U.S.C. sec. 2281 to restrain enforcement of a statute which defines unprofessional conduct of a pharmacist. We find the statutory prohibition against advertising to be valid, but we hold that the statute cannot be employed to fix the prices of prescription drugs.

In 1967, Patterson became a wholly owned subsidiary of Reveo D. S., Inc., which does business as a discount drug chain. The State Board of Pharmacy of Virginia, whose officers and members are named as defendants to this action, threatened to revoke the licenses of pharmacists employed in any Reveo Drug Center that advertised discounts or savings on prices of prescription drugs. The Board also forbade use of the slogan, “Every Day is Savings Day on Everything at Reveo,” and “America’s only Total Discount Drug Chain.” These practices, the Board charged, constituted unprofessional conduct as defined by statute and an administrative regulation which preceded it. 1 The statute upon which the Board now relies is Va.Code Ann. sec. 54-426.1 (Supp.1968), which provides in part:

“Any pharmacist shall be considered guilty of unprofessional conduct who
******
“(3) issues, publishes, broadcasts by radio or otherwise, or distributes or uses in any way whatsoever advertising matter in which grossly improbable or extravagant statements are made about his professional service which have a tendency to deceive or defraud the public, contrary to the public health and welfare; or
“(4) issues, publishes, advertises or promotes, directly or indirectly, in any manner whatsoever, any amount, price, fee, premium, discount, rebate or credit terms for professional services or for drugs containing narcotics or for any drugs which may be dispensed only by prescription.”

Alleging that the Board’s enforcement has caused it to lose substantial business, Reveo contends that the statute violates the First Amendment, the due process and equal protection clauses of the Fourteenth Amendment, and that it imposes a burden on interstate commerce and regulates matters which are the subject of exclusive federal regulation.

Williamson v. Lee Optical of Oklahoma, Inc., 348 U.S. 483, 75 S.Ct. 461, 99 L.Ed. 563 (1955), and Semler v. Oregon State Bd. of Dental Examiners, 294 U.S. 608, 55 S.Ct. 570, 79 L.Ed. 1086 (1935), sustain the statutory prohibition against advertising. 2 In Williamson an *824 optician complained that a statute forbidding the solicitation of the sale of eyeglass frames violated the due process clause of the Fourteenth Amendment. Semler concerns a similar complaint voiced by a dentist who objected to a statute that prohibited advertising the price of dental work. The Court in both instances upheld the constitutionality of the state laws. In Williamson, the Court observed that an eyeglass frame is not simply a piece of merchandise, but on the contrary it is designed to be used with lenses that affect the purchaser’s health. The Court held that the legislature “might conclude that both the sellers of frames and the sellers of lenses were in a business where advertising should be limited or even abolished in the public interest.” 3

In Semler, the prohibition against advertising was upheld against the claim, also made and proved by Reveo, that the advertisements were true. Reveo emphasizes that Semler dealt with dentists who acknowledgedly practice a profession. Reveo, therefore, seeks to avoid Semler by urging v. to hold that pharmacy is not a profession. This argument is insufficient to invalidate the statute. Virginia has found: “The practice of pharmacy * * * [is] a professional practice affecting the public health, safety and welfare and is subject to regulation and control in the public interest.” Va.Code Ann. sec. 54-399 (a) (1967). To become a registered pharmacist, the applicant must graduate from an approved school of pharmacy, have a year’s practical experience, and pass an examination. Va.Code Ann. secs. 54-421, 54-422 (1967). The Board is authorized to revoke a pharmacist’s license for unprofessional conduct. Va.Code. Ann. sec. 54-426 (1967).

Much of the evidence concerned the economics and responsibilities of the practice of pharmacy. Retail prices of prescription drugs are determined in various ways. Generally a percentage mark-v. is added to the cost. The markup often is not uniform; it may vary with the quantity of the drug prescribed. Under some pricing systems a flat fee for the pharmacist’s service is added to the retail price, but even when this is done, it is not ordinarily stated separately on the customer’s bill. Almost invariably pharmacists are paid a regular salary that does not directly depend upon the number of prescriptions filled. Annual bonuses, however, are sometimes given which reflect sales of the prescription department. Pharmacists must have extensive knowledge of a wide range of drugs. Accuracy is essential; mistakes can be serious. A few prescriptions, but nevertheless a significant number, cannot be filled from drugs available in manufactured form, so the medicine must be compounded by the pharmacists. Some pharmacists, probably a minority, systematically monitor prescriptions by family records to avoid allergic reactions or the simultaneous use of antagonistic drugs, of which the patient’s doctor may not be aware. Although monitoring is not completely effective because of the mobility of customers and the availability of nonprescription drugs which may be antagonistic, it is a benefit to the public.

From the evidence we find that dispensing prescription drugs af *825 fects the public health, safety and welfare. And we conclude that the state’s classification and regulation of pharmacy as a professional practice is not arbitrary or invidious.

Nor is the statute invalidated because Revco’s pharmacists, whose licenses are subject to revocation, do not control the corporation’s advertising and pricing policy. The state’s police power over pharmacies cannot be so simply circumscribed. Reveo cannot insulate itself from regulation because it chooses to operate through corporate subsidiaries. Cf. Semler v. Oregon State Bd. of Dental Examiners, 294 U.S. 608, 611, 55 S.Ct. 570 (1935), and Roschen v. Ward, 279 U.S. 337, 49 S.Ct. 336, 73 L.Ed. 722 (1929).

The fact that the advertising ban does not affect manufacturers and wholesalers of prescription drugs is of no legal significance. Their business differs from pharmacists’ because they do not fill prescriptions for the public.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kellogg Co. v. Mattox
763 F. Supp. 1369 (N.D. Texas, 1991)
Terry v. California State Board of Pharmacy
395 F. Supp. 94 (N.D. California, 1975)
Urowsky v. Board of Regents
76 Misc. 2d 187 (New York Supreme Court, 1973)
Maryland Board of Pharmacy v. Sav-A-Lot, Inc.
311 A.2d 242 (Court of Appeals of Maryland, 1973)
Bigelow v. Commonwealth
191 S.E.2d 173 (Supreme Court of Virginia, 1972)
Pennsylvania State Board of Pharmacy v. Pastor
272 A.2d 487 (Supreme Court of Pennsylvania, 1971)

Cite This Page — Counsel Stack

Bluebook (online)
305 F. Supp. 821, 1969 U.S. Dist. LEXIS 13120, 1970 Trade Cas. (CCH) 73,097, Counsel Stack Legal Research, https://law.counselstack.com/opinion/patterson-drug-company-v-kingery-vawd-1969.